Clinical trial

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

NCT00003418

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1998-02-01

PhasePHASE3

Study timeline

Study start (unknown)1998-02-01Date precision: month

Registry last updated2013-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

exemestaneDRUG · verified · RxNorm: exemestane

tamoxifen citrateDRUG · verified · RxNorm: tamoxifen citrate

Sponsors & collaborators

International Collaborative Cancer Grouplead sponsor

European Organisation for Research and Treatment of Cancer - EORTCcollaborator

UNICANCERcollaborator

Mapped research locations

LeuvenBelgium1 NiceFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003418 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.